IL6 and acute respiratory distress syndrome: Higher levels of IL-6 seem to be associated with the severity of the disease (56, 107, 108), even though it has been reported that circulating IL-6 levels are lower in COVID-19 patients compared to what is observed in other pathological conditions, such as acute respiratory disease syndrome (ARDS) and cytokine release syndrome (CRS) (124).